Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy.
about
Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment ChoicesGadolinium-based contrast agent toxicity: a review of known and proposed mechanismsMRI/MRS in neuroinflammation: methodology and applications25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future PerspectivesComputed Tomography and Cardiac Magnetic Resonance in Ischemic Heart DiseaseClinical Breast MR Using MRS or DWI: Who Is the Winner?Effects of Gadolinium-Based Contrast Agents on Thyroid Hormone Receptor Action and Thyroid Hormone-Induced Cerebellar Purkinje Cell MorphogenesisLabel-free CEST MRI Detection of Citicoline-Liposome Drug Delivery in Ischemic StrokeSyMRI of the Brain: Rapid Quantification of Relaxation Rates and Proton Density, With Synthetic MRI, Automatic Brain Segmentation, and Myelin Measurement.National Institutes of Health Perspective on Reports of Gadolinium Deposition in the Brain.Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.Contribution of metals to brain MR signal intensity: review articles.T1 hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition?Structure and dysprosium dopant engineering of gadolinium oxide nanoparticles for enhanced dual-modal magnetic resonance and fluorescence imaging.Non-caloric sweetener provides magnetic resonance imaging contrast for cancer detection.Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.Gadolinium-based contrast agents: did we miss something in the last 25 years?Off-resonance magnetic resonance angiography improves visualization of in-stent lumen in peripheral nitinol stents compared to conventional T1-weighted acquisitions: an in vitro comparison study.Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.Gadolinium retention in the body: what we know and what we can do.MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats.A Manganese Alternative to Gadolinium for MRI Contrast.Considerations for Imaging the Inferior Vena Cava (IVC) with/without IVC Filters.Sodium MRI in Multiple Sclerosis is Compatible with Intracellular Sodium Accumulation and Inflammation-Induced Hyper-Cellularity of Acute Brain Lesions.Safety of Gadobutrol: Results From 42 Clinical Phase II to IV Studies and Postmarketing Surveillance After 29 Million ApplicationsHigh signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification.Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent.Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update.Recommendations on the use of MRI in PSC-A position statement from the International PSC study group.Off-resonance based assessment of metallic wear debris near total hip arthroplasty.Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI.Survey of gadolinium-based contrast agent utilization among the members of the Society for Pediatric Radiology: a Quality and Safety Committee report.Cardiac MRI and Ischemic Heart Disease: Role in Diagnosis and Risk Stratification.The Impact of Excess Ligand on the Retention of Nonionic, Linear Gadolinium-Based Contrast Agents in Patients With Various Levels of Renal Dysfunction: A Review and Simulation Analysis.Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study.Melanoma central nervous system metastases: current approaches, challenges, and opportunities.Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.MRI surveillance of vestibular schwannomas without contrast enhancement: Clinical and economic evaluation.
P2860
Q26748229-C346E618-BBC6-463C-B82A-37176C0B3A8EQ26751073-3A801441-D102-4395-A393-BF9FC48A8780Q26771930-AC3E1FD3-E7D3-4CFB-9B90-D86E01E77835Q26774810-12FDC215-D1EE-4E96-9C02-EEEE57976979Q28066080-9CB4A4F2-A505-4B89-AD23-AFC795D8A0DCQ28072837-D73B4202-CA5D-437B-8966-6A6BBE2B3F83Q28828872-9C213127-6792-436F-B32A-C9AC7BB05575Q28829493-59B8E4C5-46A0-4ED6-890A-7FFE2BA96A18Q30491047-3C8E8457-3106-4CA3-8BEF-94B1AAE3DBBAQ31039888-8DAFF8D0-39D8-4A70-9B36-60D908A0BC5EQ31045014-7B62A8D6-14E0-4CA1-81B7-F56B7C3315BEQ31051153-A2092E4B-6EA9-4731-8A3D-3CD890A77371Q31132207-CEE116C3-55E3-4B4E-97FB-FF7356EE1452Q31159248-F598991C-3EEF-4D56-A33F-49F4AE1A0250Q33743741-B0E38FF3-C0DC-42F8-A969-65E8D244D18AQ33778968-F4375DD2-DF1C-41CF-A676-F3140714A9CDQ35878856-06C6398E-711F-4858-BDB1-CFEBD74C1742Q36106277-96786C3B-440B-4571-8C11-CF2D9232D709Q36316226-79FD2002-F57E-4000-96B5-87AE92E473A3Q36329191-DE19270C-8629-4E30-B50A-8A88CCBDFFCFQ36400004-FF06815F-ABB9-4674-A5CE-E00F825F06ECQ36564222-AC6180FD-0E21-4C5C-95BF-4E7CDC77D6E5Q36609886-ED34E851-3ED2-4F33-8243-FF7126C6C730Q36888994-72158DB3-B985-44B4-8A0C-45B9388CF94CQ37163249-B4DD05B4-8172-4254-B89A-9F03EA755929Q37170996-E43BCF6F-C101-4BCE-BCA6-6ABA479E12C4Q37344053-E9FEAF08-E3C8-4318-89A4-3ECB76AD1DABQ37510442-D978D92F-C808-4986-B86A-B84154B565FCQ37605738-9AEAD467-BD36-4721-A516-96A311F93A37Q38667169-49164B3A-5E37-4426-B604-5606E3AC3D4EQ38677506-AE57D6BC-7E0F-421C-B419-4F5550E15FBCQ38712671-E6D31284-0622-42BB-B8F2-7049DE443C4AQ38716380-7DA71720-FFDD-4F13-B1BD-4057E00F9F66Q38747409-F896A41F-88D3-495F-98E1-BF4E34D8241CQ38776041-EBE5EADF-68D3-4D5D-926E-C1D6B401CC25Q38788045-D3DA1FC9-E98B-46E4-95BB-782E6E54C86EQ38790916-AA903F98-DF10-422E-9B6E-C93225BFFC69Q38807942-B1F578EA-D9D8-436A-807A-464D12CB69B3Q38837567-F1A9345D-E314-49DD-90F3-9FEF6129C6B0Q38843176-A98E250E-94EF-421F-BD14-47630A2F1DD6
P2860
Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Gadolinium-based Contrast Agen ...... pled Plasma Mass Spectroscopy.
@en
type
label
Gadolinium-based Contrast Agen ...... pled Plasma Mass Spectroscopy.
@en
prefLabel
Gadolinium-based Contrast Agen ...... pled Plasma Mass Spectroscopy.
@en
P2093
P1433
P1476
Gadolinium-based Contrast Agen ...... pled Plasma Mass Spectroscopy.
@en
P2093
Hiroshi Oba
Jun'ichi Kotoku
Kazuhiro Kitajima
Keiko Toyoda
Megumi Matsuda
Shigeru Furui
Takahiro Haruyama
Tomonori Kanda
Toshio Fukusato
P304
P356
10.1148/RADIOL.2015142690
P407
P577
2015-05-05T00:00:00Z